Biomapas Logo
cropped-favicon-biomapas.png

Effective IMPD Writing. The Quality Part

Effective IMPD Writing: The Quality Part

Webinar: Effective IMPD Writing. The Quality Part

Effective IMPD writing, including the quality part is a vital document that contains information about an investigational medicinal product and it is an essential part of the Clinical Trial Application (CTA), which is required by competent authorities in EU.

The purpose of this webinar is to share the best practices in the preparation of IMPD in order to meet the expectations of competent authorities and to learn why effective CMC technical writing is crucial for the development of a high quality IMPD.

 

You will learn about:

1. Regulatory guidelines for the Investigational Medicinal Product Dossier

2. IMPD structure and content

3. Best practices for the preparation of IMPD

  • Best practices in IMPD Quality writing;
  • Writing style to produce accurate, concise, and clear technical text.

 

Starting Clinical Trials?

Make use of our expertise to smoothly prepare for clinical studies. Explore your options in a chat with one of our experts.

Who should attend? Professionals from the following fields:

  • Regulatory
  • R&D
  • QA/QC
  • Compliance
  • Product Development
  • Manufacturing

Duration: 40 min.

Speakers:

  • Head of the Central Functions for Regulatory Affairs, Ramunė Rūkienė;
  • Medical Writer, Eglė Deimantavičiūtė.
Ramunė Rūkienė, MSc

Ramunė Rūkienė, MSc

Head of Regulatory Affairs Central Operations

Other content that might interest you:

Biosimilars in the MENA Region: Regulatory Landscape

Biosimilars in the MENA Region: Regulatory Landscape

Regulatory affairs for biosimilars in Middle East North Africa (MENA) region are evolving as existing guidelines and regulatory frameworks are being updated. Since European Medicines Agency (EMA) introduced a legal pathway for biosimilars approval in 2004, several...

read more
Saudi FDA’s New Pricing Guidelines and Impact on the Region

Saudi FDA’s New Pricing Guidelines and Impact on the Region

In a highly evolving regional pricing environment, Saudi Arabia (KSA) is no exception. The Saudi Food and Drug Authority (SFDA) has been periodically reviewing its pricing mechanisms and criteria so that the country becomes a regional reference for the prices of pharmaceutical products. What followed is a change in the pricing strategy by SFDA and a shift from price takers to price makers.

read more
Medical Device Registration in Russia. Challenges and Issues

Medical Device Registration in Russia. Challenges and Issues

Webinar: Medical Device Registration in Russia. Challenges and Issues The purpose of this webinar is to show the differences and specifics of regulations and law processes that can cause challenges in medical device registration in Russia.   You will learn about:...

eCTD Submission Strategies: In-house vs. Outsourcing

eCTD Submission Strategies: In-house vs. Outsourcing

Webinar: eCTD Submission Different Strategies: In-house vs. Outsourcing eCTD Submission Strategies, including outsourcing, are influenced by varying requirements in various regions and countries. That and diverse technical resources by companies often lead to various...

Drugs serialization and barcoding in Saudi Arabia and MENA region

Drugs serialization and barcoding in Saudi Arabia and MENA region

  An increasing number of countries worldwide have enacted regulations mandating serialization, tracking and tracing of pharmaceutical products down the supply chain during recent years as a response to drug integrity concerns. There are plenty of laws requiring...

eCTD implementation across MENA region: What is the current status?

eCTD implementation across MENA region: What is the current status?

As the electronic Common Technical Document (eCTD) became the standard for submitting Regulatory Information to leading agencies worldwide, its adoption still poses a considerable challenge for those agencies who lack the needed human and/or material resources. How is...

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information